Skip to main content
. 2021 Apr 10;74(Suppl 2):3399–3406. doi: 10.1007/s12070-021-02540-w

Table 2.

Showing distribution of comorbidities amongst COVID 19 patients with chemosensory dysfunction

Comorbidites Ageusia (n = 14) Anosmia (n = 9) Ageusia and Anosmia (n = 8) Total (n = 31)
Hypertension 2(50%) 1(33.33%) 1(50%) 4 (44.44%)
Diabetes 1(25%) 1(33.33%) 1(50%) 3(33.33%)
Asthma/COPD 1(33.33%) 1(11.11%)
Thyroid Diseases 1 (25%) 1(11.11%)
Heart diseases
Renal diseases
Total 4 (28.75%) 3 (33.33%) 2(25%) 9(29%)